Page last updated: 2024-10-25

deferoxamine and Carcinoma 256, Walker

deferoxamine has been researched along with Carcinoma 256, Walker in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degasperi, GR1
Castilho, RF1
Vercesi, AE1

Other Studies

1 other study available for deferoxamine and Carcinoma 256, Walker

ArticleYear
High susceptibility of activated lymphocytes to oxidative stress-induced cell death.
    Anais da Academia Brasileira de Ciencias, 2008, Volume: 80, Issue:1

    Topics: Animals; Apoptosis; Calcium; Carcinoma 256, Walker; Chelating Agents; Deferoxamine; Egtazic Acid; Fl

2008